2 Magnificent S&P 500 Dividend Stocks Down as Much as 55% to Buy and Hold Forever

UPS's U.S. revenue per piece rose 7.1% in 2025 after a network overhaul that saved roughly $3.5 billion (93 buildings closed, automation at 57 sites), and management expects 2026 to be the inflection year; the stock yields ~6.9%. Hormel has recorded five consecutive quarters of rising organic sales, has divested its commodity turkey business, and projects adjusted earnings growth of 4%–10% in fiscal 2026 with a ~5% dividend yield. Both names are down over 55% since early 2022, presenting a potential buy-the-dip opportunity if turnarounds materialize.

Analysis

The market has priced both UPS and Hormel as slow-recovery, high-yield stories; that discount increases optionality for asymmetric trades if operational fixes and portfolio reshaping continue to compound. UPS’s automation and network pruning create a levered margin profile: every 1% sustained increase in revenue-per-piece beyond inflation should flow almost fully to EBIT after fixed-cost absorption in 12–24 months, amplifying EPS on flat volumes. Hormel’s pivot into value‑added protein and the exit from commodity turkey shifts revenue mix toward higher gross margin SKUs; coupled with a 5% yield, this creates a low-beta equity with a yield cushion that buys time for a multi-quarter margin recovery. Second-order winners include regional carriers and third‑party integrators that can pick up residual volume during UPS network reconfigurations, and grocery/foodservice customers who can lock preferred supply from a leaner Hormel — both create timing risks for working capital and short-term revenue volatility for the majors.

Key tail risks are macro-driven volume declines and contract repricing. For UPS, an elongated e-commerce stall or renewed pressure from Amazon (rate renegotiation or accelerated in‑sourcing) could erase the expected margin tailwind within a single contract cycle (6–18 months). For Hormel, the GLP‑1 consumption thesis is asymmetric: if population dietary shifts don’t materialize or input inflation re‑accelerates, the positive mix could be offset, compressing the 5% yield buffer. Near-term catalysts to monitor are (1) UPS pricing cadence and Y/Y revenue-per-piece in each U.S. pricing bucket over the next 2 quarters, and (2) Hormel’s quarterly margin mix and guidance cadence across retail vs. foodservice over the next 4 quarters.

Market positioning is complacent on timeline risk: yields imply shareholders expect a multi-year grind, not a 6–12 month inflection. That offers two practical approaches — buy-and-wait with income underwriting (dividend capture + downside cushions) or convex, time‑limited optional exposure to a 2026 H2 turnaround. The optimal risk layering is short-dated income trades to collect premium while buying longer-dated call optionality to capture the operational slack becoming visible in late-2026 results.

Key Decisions for Investors

• Long UPS LEAPs: Buy UPS Jan-2028 calls (or equivalent 18–30 month expiry) to capture a H2-2026 inflection. Risk: premium paid (100% downside). Reward: +30–60% equity-equivalent return if revenue-per-piece sustains a 5–7% CAGR into 2026 and margins expand as planned. Use position size = 1–2% NAV.
• Income + optionality on UPS: Sell cash‑secured UPS puts 6–12 months OTM (~8–12% below current price) to harvest premium and set entry should the market test levels. Risk: assignment and capture of dividend liability. Reward: effective yield on committed capital of mid‐single digits plus potential to own UPS at a lower basis; combine with 0.5–1% notional long call to retain upside exposure.
• Covered-income bias on HRL: Buy HRL equity and sell 9–12 month covered calls roughly at 10–15% OTM to harvest the 5% dividend plus call premium. Risk: significant downside if staples re‑rating occurs (~‑15–20% over 12 months). Reward: 8–15% blended yield + limited upside capture if the market re-rates as margins expand.
• Relative-value hedge: Long HRL vs short SPY (equal dollar) for 6–12 months to isolate food‑specific alpha (protein mix and restructuring). Risk: if broad market rallies faster than staples, this trade can lag; cap loss by sizing to 0.5–1% NAV and monitor correlation. Reward: expected outperformance of 6–12% if Hormel execution continues and staples re-rate independently of the market.